Eric H Yang
Overview
Explore the profile of Eric H Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
204
Citations
2245
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nassar A, Abou Alaiwi S, El Zarif T, Denu R, Macaron W, Abdel-Wahab N, et al.
J Immunother Cancer
. 2025 Mar;
13(3).
PMID: 40032601
Background: Data on the safety profiles and clinical outcomes of patients with solid tumors and cardiac metastasis treated with immune checkpoint inhibitors (ICIs) are limited. Methods: This is an international...
2.
Liu O, Soo S, Bloom M, Alvarez-Cardona J, Katz J, Cheng R, et al.
Eur Heart J Acute Cardiovasc Care
. 2025 Feb;
PMID: 39992871
Background: Acute decompensated heart failure (HF) can progress to cardiogenic shock, and patients with cancer are at an increased risk of HF compared to patients without cancer. However, limited data...
3.
Erbay M, Manubolu V, Stein-Merlob A, Ferencik M, Mamas M, Lopez-Mattei J, et al.
Curr Cardiol Rep
. 2025 Feb;
27(1):51.
PMID: 39932640
Purpose Of Review: Cardiovascular computed tomography (CCT) is a versatile, readily available, and non-invasive imaging tool with high-resolution capabilities in many cardiovascular diseases (CVD). Our review explains the increased risk...
4.
Bhatti A, Patel R, Dani S, Khadke S, Makwana B, Lessey C, et al.
JACC CardioOncol
. 2025 Jan;
6(6):863-875.
PMID: 39801650
Background: Specific cancer treatments can lead to cancer therapy-related cardiac dysfunction (CTRCD). Sodium glucose cotransporter-2 inhibitors (SGLT2is) can potentially prevent these cardiotoxic effects. Objectives: This study sought to determine whether...
5.
Agarwal S, Qamar U, Khan M, Al-Juhaishi T, Naqash A, Guha A, et al.
Eur Heart J Open
. 2025 Jan;
5(1):oeae101.
PMID: 39781540
Aims: We aimed to perform a retrospective cohort study using the Centers for Disease Control and Prevention's (CDC's) Wide-Ranging Online Data for Epidemiologic Research (WONDER) database to analyse the trends...
6.
Khattab M, Baig M, El Zarif T, Barac A, Ferencik M, Henry M, et al.
Circ Cardiovasc Imaging
. 2025 Jan;
18(1):e015981.
PMID: 39772610
It is well understood that cancer therapies including chemotherapy, tyrosine kinase inhibitors, immune checkpoint inhibitors, and radiation can increase the risk of cardiovascular disease in patients with cancer. This can...
7.
Bravo-Jaimes K, Venkatesh P, Lluri G, Reardon L, Cruz D, Vucicevic D, et al.
Int J Cardiol Congenit Heart Dis
. 2024 Dec;
8:100361.
PMID: 39712065
No abstract available.
8.
Day A, Mitchell D, Eary R, Jones E, Pinho M, Zaha V, et al.
Cancer
. 2024 Nov;
131(1):e35639.
PMID: 39589466
No abstract available.
9.
Stein-Merlob A, Yang E
Cardiol Clin
. 2024 Nov;
43(1):xiii-xv.
PMID: 39551566
No abstract available.
10.
Hutchins E, Yang E, Stein-Merlob A
Curr Cardiol Rep
. 2024 Oct;
26(12):1329-1340.
PMID: 39377963
Purpose Of Review: In this review we describe the role of inflammation in chemotherapy-induced cardiotoxicity with a particular focus on anthracycline-induced cardiomyopathy (AIC). First, we discuss inflammation associated with anthracyclines...